{"transactions":[{"id":678895,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-08-21T20:49:40.000Z","date":"2026-08-19","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001521111-26-000005","document":"form4-08212026_080836.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111126000005/form4-08212026_080836.xml","form_type":"4"}},{"id":678894,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-08-21T20:49:40.000Z","date":"2026-08-19","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":7.0924,"value":709240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.02 to $7.21. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001521111-26-000005","document":"form4-08212026_080836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111126000005/form4-08212026_080836.xml","form_type":"4"}},{"id":678893,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-08-21T20:49:40.000Z","date":"2026-08-19","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":1.87,"value":187000.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001521111-26-000005","document":"form4-08212026_080836.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111126000005/form4-08212026_080836.xml","form_type":"4"}},{"id":707118,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":29802,"kind":"person","name":"Sauvage Philippe","position":1,"cik":"0002039891","reported_name":"Sauvage Philippe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T22:27:20.000Z","date":"2026-07-15","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of February 28, 2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":499999,"derivative":{"exercise_price":1.97,"expiration_date":"2035-02-27","underlying":"Class A Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0002039891-26-000008","document":"form4-07172026_100715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2039891/000203989126000008/form4-07172026_100715.xml","form_type":"4"}},{"id":707117,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":29802,"kind":"person","name":"Sauvage Philippe","position":1,"cik":"0002039891","reported_name":"Sauvage Philippe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T22:27:20.000Z","date":"2026-07-15","kind":"exercise","planned":false,"acquired":false,"shares":39999,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of October 7, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":662333,"derivative":{"exercise_price":2.17,"expiration_date":"2034-10-06","underlying":"Class A Common Stock","underlying_shares":39999},"source":{"system":"sec-edgar","filing":"0002039891-26-000008","document":"form4-07172026_100715.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2039891/000203989126000008/form4-07172026_100715.xml","form_type":"4"}},{"id":707116,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":29802,"kind":"person","name":"Sauvage Philippe","position":1,"cik":"0002039891","reported_name":"Sauvage Philippe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-17T22:27:20.000Z","date":"2026-07-15","kind":"exercise","planned":false,"acquired":true,"shares":1,"price":1.97,"value":1.97,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,458 shares purchased through the issuer's employee stock purchase plan on May 19, 2026."}],"balance_after":54131,"source":{"system":"sec-edgar","filing":"0002039891-26-000008","document":"form4-07172026_100715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039891/000203989126000008/form4-07172026_100715.xml","form_type":"4"}},{"id":707115,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":29802,"kind":"person","name":"Sauvage Philippe","position":1,"cik":"0002039891","reported_name":"Sauvage Philippe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-07-17T22:27:20.000Z","date":"2026-07-15","kind":"exercise","planned":false,"acquired":true,"shares":39999,"price":2.17,"value":86797.83,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,458 shares purchased through the issuer's employee stock purchase plan on May 19, 2026."}],"balance_after":54130,"source":{"system":"sec-edgar","filing":"0002039891-26-000008","document":"form4-07172026_100715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039891/000203989126000008/form4-07172026_100715.xml","form_type":"4"}},{"id":727746,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T23:09:49.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":false,"shares":34620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests as to 25% on September 30, 2020 and in equal monthly installments thereafter over the following three years, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":220190,"derivative":{"exercise_price":1.74,"expiration_date":"2030-01-21","underlying":"Class A Common Stock","underlying_shares":34620},"source":{"system":"sec-edgar","filing":"0001734780-26-000004","document":"form4-06242026_110645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/form4-06242026_110645.xml","form_type":"4"}},{"id":727745,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T23:09:49.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":false,"shares":90380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of February 29, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":409620,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":90380},"source":{"system":"sec-edgar","filing":"0001734780-26-000004","document":"form4-06242026_110645.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/form4-06242026_110645.xml","form_type":"4"}},{"id":727744,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:09:49.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":125000,"price":6.0255,"value":753187.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.085. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":32591,"source":{"system":"sec-edgar","filing":"0001734780-26-000004","document":"form4-06242026_110645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/form4-06242026_110645.xml","form_type":"4"}},{"id":727743,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:09:49.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":true,"shares":34620,"price":1.74,"value":60238.8,"ownership":{"direct":true},"balance_after":157591,"source":{"system":"sec-edgar","filing":"0001734780-26-000004","document":"form4-06242026_110645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/form4-06242026_110645.xml","form_type":"4"}},{"id":727742,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:09:49.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":true,"shares":90380,"price":1.87,"value":169010.6,"ownership":{"direct":true},"balance_after":122971,"source":{"system":"sec-edgar","filing":"0001734780-26-000004","document":"form4-06242026_110645.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000004/form4-06242026_110645.xml","form_type":"4"}},{"id":727741,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T23:07:53.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":false,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of August 29, 2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":152250,"derivative":{"exercise_price":2.93,"expiration_date":"2032-08-28","underlying":"Class A Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001369453-26-000008","document":"form4-06242026_110649.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000008/form4-06242026_110649.xml","form_type":"4"}},{"id":727740,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:07:53.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":63000,"price":6.0189,"value":379190.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.08. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":53000,"source":{"system":"sec-edgar","filing":"0001369453-26-000008","document":"form4-06242026_110649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000008/form4-06242026_110649.xml","form_type":"4"}},{"id":727739,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:07:53.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":true,"shares":63000,"price":2.93,"value":184590.0,"ownership":{"direct":true},"balance_after":116000,"source":{"system":"sec-edgar","filing":"0001369453-26-000008","document":"form4-06242026_110649.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000008/form4-06242026_110649.xml","form_type":"4"}},{"id":727922,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":29802,"kind":"person","name":"Sauvage Philippe","position":1,"cik":"0002039891","reported_name":"Sauvage Philippe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-24T23:07:16.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":false,"shares":47668,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of October 7, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":702332,"derivative":{"exercise_price":2.17,"expiration_date":"2034-10-06","underlying":"Class A Common Stock","underlying_shares":47668},"source":{"system":"sec-edgar","filing":"0002039891-26-000006","document":"form4-06242026_110612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2039891/000203989126000006/form4-06242026_110612.xml","form_type":"4"}},{"id":727921,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":29802,"kind":"person","name":"Sauvage Philippe","position":1,"cik":"0002039891","reported_name":"Sauvage Philippe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:07:16.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":47668,"price":6.0076,"value":286370.2768,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $6.00 to $6.04. The Reporting Person will provide, upon request, to the Securities and Exchange Commission, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":12673,"source":{"system":"sec-edgar","filing":"0002039891-26-000006","document":"form4-06242026_110612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039891/000203989126000006/form4-06242026_110612.xml","form_type":"4"}},{"id":727920,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":29802,"kind":"person","name":"Sauvage Philippe","position":1,"cik":"0002039891","reported_name":"Sauvage Philippe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2026-06-24T23:07:16.000Z","date":"2026-06-23","kind":"exercise","planned":true,"acquired":true,"shares":47668,"price":2.17,"value":103439.56,"ownership":{"direct":true},"balance_after":60341,"source":{"system":"sec-edgar","filing":"0002039891-26-000006","document":"form4-06242026_110612.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039891/000203989126000006/form4-06242026_110612.xml","form_type":"4"}},{"id":741977,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":39335,"kind":"person","name":"Mashal Robert","position":1,"cik":"0002007102","reported_name":"Mashal Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2026-06-12T00:02:51.000Z","date":"2026-06-09","kind":"purchase","planned":false,"acquired":true,"shares":25000,"price":4.73,"value":118250.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee."}],"balance_after":225000,"source":{"system":"sec-edgar","filing":"0002007102-26-000004","document":"form4-06122026_120648.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007102/000200710226000004/form4-06122026_120648.xml","form_type":"4"}},{"id":763909,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40917,"kind":"person","name":"VERNON W ANTHONY","position":1,"cik":"0001369091","reported_name":"VERNON W ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-27T00:07:56.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":123397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":123397,"derivative":{"exercise_price":4.79,"expiration_date":"2036-05-20","underlying":"Class A Common Stock","underlying_shares":123397},"source":{"system":"sec-edgar","filing":"0001369091-26-000003","document":"form4-05272026_120552.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136909126000003/form4-05272026_120552.xml","form_type":"4"}},{"id":764085,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":39335,"kind":"person","name":"Mashal Robert","position":1,"cik":"0002007102","reported_name":"Mashal Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-27T00:07:03.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":123397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":123397,"derivative":{"exercise_price":4.79,"expiration_date":"2036-05-20","underlying":"Class A Common Stock","underlying_shares":123397},"source":{"system":"sec-edgar","filing":"0002007102-26-000002","document":"form4-05272026_120559.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007102/000200710226000002/form4-05272026_120559.xml","form_type":"4"}},{"id":763908,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":38755,"kind":"person","name":"FALBERG KATHRYN E","position":1,"cik":"0001206977","reported_name":"FALBERG KATHRYN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-27T00:05:50.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":123397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":123397,"derivative":{"exercise_price":4.79,"expiration_date":"2036-05-20","underlying":"Class A Common Stock","underlying_shares":123397},"source":{"system":"sec-edgar","filing":"0001206977-26-000006","document":"form4-05272026_120546.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000120697726000006/form4-05272026_120546.xml","form_type":"4"}},{"id":763907,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":44250,"kind":"person","name":"BLICKENSTAFF KIM D","position":1,"cik":"0001238913","reported_name":"BLICKENSTAFF KIM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-27T00:04:33.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":123397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":123397,"derivative":{"exercise_price":4.79,"expiration_date":"2036-05-20","underlying":"Class A Common Stock","underlying_shares":123397},"source":{"system":"sec-edgar","filing":"0001238913-26-000002","document":"form4-05272026_120529.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000123891326000002/form4-05272026_120529.xml","form_type":"4"}},{"id":763906,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":36784,"kind":"person","name":"Bazemore Robert B","position":1,"cik":"0001620152","reported_name":"Bazemore Robert B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-27T00:03:27.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":123397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":123397,"derivative":{"exercise_price":4.79,"expiration_date":"2036-05-20","underlying":"Class A Common Stock","underlying_shares":123397},"source":{"system":"sec-edgar","filing":"0001620152-26-000003","document":"form4-05272026_120523.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000162015226000003/form4-05272026_120523.xml","form_type":"4"}},{"id":763905,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-27T00:01:53.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":123397,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2026); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":123397,"derivative":{"exercise_price":4.79,"expiration_date":"2036-05-20","underlying":"Class A Common Stock","underlying_shares":123397},"source":{"system":"sec-edgar","filing":"0001487815-26-000007","document":"form4-05272026_120549.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000148781526000007/form4-05272026_120549.xml","form_type":"4"}},{"id":763903,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-27T00:01:13.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":76923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 3, 2026, the reporting person filed a Form 4 which, due to an administrative error, incorrectly reported that the reporting person was awarded 74,813 options to purchase Class A Common Stock on February 27, 2026. In fact, the reporting person was awarded 76,923 options to purchase Class A Common Stock on such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 1/24 of the shares on the one month anniversary of 1/1/2026, monthly thereafter over the following 23 months, subject to Reporting Person's continuous service on each such vesting date"}],"balance_after":76923,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":76923},"source":{"system":"sec-edgar","filing":"0001487815-26-000006","document":"form4a-05272026_120510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000148781526000006/form4a-05272026_120510.xml","form_type":"4/A","original_submission_date":"2026-03-03"}},{"id":803764,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T20:35:16.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":false,"shares":36750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of August 29, 2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":215250,"derivative":{"exercise_price":2.93,"expiration_date":"2032-08-28","underlying":"Class A Common Stock","underlying_shares":36750},"source":{"system":"sec-edgar","filing":"0001369453-26-000006","document":"form4-04212026_080412.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000006/form4-04212026_080412.xml","form_type":"4"}},{"id":803763,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-21T20:35:16.000Z","date":"2026-04-17","kind":"sale","planned":true,"acquired":false,"shares":36750,"price":5.0144,"value":184279.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.05. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":53000,"source":{"system":"sec-edgar","filing":"0001369453-26-000006","document":"form4-04212026_080412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000006/form4-04212026_080412.xml","form_type":"4"}},{"id":803762,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-21T20:35:16.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":true,"shares":36750,"price":2.93,"value":107677.5,"ownership":{"direct":true},"balance_after":89750,"source":{"system":"sec-edgar","filing":"0001369453-26-000006","document":"form4-04212026_080412.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000006/form4-04212026_080412.xml","form_type":"4"}},{"id":803758,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-21T20:34:07.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on February 28, 2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date"}],"balance_after":430000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-02-27","underlying":"Class A Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001937915-26-000004","document":"form4-04212026_080401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791526000004/form4-04212026_080401.xml","form_type":"4"}},{"id":803757,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-21T20:34:07.000Z","date":"2026-04-17","kind":"sale","planned":true,"acquired":false,"shares":50000,"price":5.02,"value":251000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.07. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001937915-26-000004","document":"form4-04212026_080401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791526000004/form4-04212026_080401.xml","form_type":"4"}},{"id":803756,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-21T20:34:07.000Z","date":"2026-04-17","kind":"exercise","planned":true,"acquired":true,"shares":50000,"price":1.94,"value":97000.0,"ownership":{"direct":true},"balance_after":68000,"source":{"system":"sec-edgar","filing":"0001937915-26-000004","document":"form4-04212026_080401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791526000004/form4-04212026_080401.xml","form_type":"4"}},{"id":812607,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-08T20:23:17.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-02-27","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001369453-26-000005","document":"form4-04082026_080413.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/form4-04082026_080413.xml","form_type":"4"}},{"id":812606,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-08T20:23:17.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":400000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001369453-26-000005","document":"form4-04082026_080413.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/form4-04082026_080413.xml","form_type":"4"}},{"id":812605,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:23:17.000Z","date":"2026-04-06","kind":"sale","planned":true,"acquired":false,"shares":200000,"price":4.5178,"value":903560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated December 4, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $4.44 to $4.64. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":53000,"source":{"system":"sec-edgar","filing":"0001369453-26-000005","document":"form4-04082026_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/form4-04082026_080413.xml","form_type":"4"}},{"id":812604,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:23:17.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":1.94,"value":194000.0,"ownership":{"direct":true},"balance_after":253000,"source":{"system":"sec-edgar","filing":"0001369453-26-000005","document":"form4-04082026_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/form4-04082026_080413.xml","form_type":"4"}},{"id":812603,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2026-04-08T20:23:17.000Z","date":"2026-04-06","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":1.87,"value":187000.0,"ownership":{"direct":true},"balance_after":153000,"source":{"system":"sec-edgar","filing":"0001369453-26-000005","document":"form4-04082026_080413.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000005/form4-04082026_080413.xml","form_type":"4"}},{"id":867966,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T01:04:44.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":748130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":748130,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":748130},"source":{"system":"sec-edgar","filing":"0001937915-26-000003","document":"form4-03042026_010341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791526000003/form4-03042026_010341.xml","form_type":"4"}},{"id":868528,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":63404,"kind":"person","name":"Makunje Moses","position":1,"cik":"0002001938","reported_name":"Makunje Moses","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T01:03:31.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":224439,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of 2/27/26, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":224439,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":224439},"source":{"system":"sec-edgar","filing":"0002001938-26-000004","document":"form4-03042026_010328.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2001938/000200193826000004/form4-03042026_010328.xml","form_type":"4"}},{"id":868527,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":63404,"kind":"person","name":"Makunje Moses","position":1,"cik":"0002001938","reported_name":"Makunje Moses","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Class A Common Stock","published_at":"2026-03-04T01:03:31.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":50761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the grant of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement.  25% of the shares subject to the RSUs shall vest on the Issuer's quarterly vesting date following each of the first four anniversaries from 2/27/2026, subject to Reporting Person's continuous service on each such vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,001 shares acquired on May 19, 2025 and 1,100 shares acquired November 19, 2025 under the 2021 Employee Stock Purchase Plan."}],"balance_after":68137,"source":{"system":"sec-edgar","filing":"0002001938-26-000004","document":"form4-03042026_010328.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2001938/000200193826000004/form4-03042026_010328.xml","form_type":"4"}},{"id":867965,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T01:02:37.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":748130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":748130,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":748130},"source":{"system":"sec-edgar","filing":"0001369453-26-000003","document":"form4-03042026_010334.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000136945326000003/form4-03042026_010334.xml","form_type":"4"}},{"id":868907,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":29802,"kind":"person","name":"Sauvage Philippe","position":1,"cik":"0002039891","reported_name":"Sauvage Philippe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T01:00:20.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":748130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":748130,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":748130},"source":{"system":"sec-edgar","filing":"0002039891-26-000003","document":"form4-03042026_010301.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039891/000203989126000003/form4-03042026_010301.xml","form_type":"4"}},{"id":867964,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T00:59:11.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":748130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":748130,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":748130},"source":{"system":"sec-edgar","filing":"0001734780-26-000003","document":"form4-03042026_120307.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000173478026000003/form4-03042026_120307.xml","form_type":"4"}},{"id":867963,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":44249,"kind":"person","name":"Cui Xiangmin","position":1,"cik":"0001487815","reported_name":"Cui Xiangmin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T00:58:08.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":74813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 1/24 of the shares on the one month anniversary of 1/1/2026, monthly thereafter over the following 23 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":74813,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":74813},"source":{"system":"sec-edgar","filing":"0001487815-26-000003","document":"form4-03042026_120305.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000148781526000003/form4-03042026_120305.xml","form_type":"4"}},{"id":867962,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T00:57:16.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":748130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":748130,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":748130},"source":{"system":"sec-edgar","filing":"0001521111-26-000003","document":"form4-03042026_120312.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111126000003/form4-03042026_120312.xml","form_type":"4"}},{"id":867961,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-04T00:50:55.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":1995012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":1995012,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":1995012},"source":{"system":"sec-edgar","filing":"0001310880-26-000003","document":"form4-03042026_120352.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000131088026000003/form4-03042026_120352.xml","form_type":"4"}},{"id":868683,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":63418,"kind":"person","name":"Sjogren Colleen","position":1,"cik":"0002017751","reported_name":"Sjogren Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T20:01:48.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":748130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":748130,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":748130},"source":{"system":"sec-edgar","filing":"0002017751-26-000003","document":"form4-03042026_010344.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2017751/000201775126000003/form4-03042026_010344.xml","form_type":"4"}},{"id":868155,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":63378,"kind":"person","name":"Hanley David C.","position":1,"cik":"0001865826","reported_name":"Hanley David C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPERATIONS"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T19:52:19.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":748130,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/27/2026, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":748130,"derivative":{"exercise_price":5.91,"expiration_date":"2036-02-26","underlying":"Class A Common Stock","underlying_shares":748130},"source":{"system":"sec-edgar","filing":"0001865826-26-000003","document":"form4-03042026_120316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865826/000186582626000003/form4-03042026_120316.xml","form_type":"4"}},{"id":981683,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-12-03T22:02:12.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":false,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vested as to 25% on the one year anniversary of 8/29/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date"}],"balance_after":165000,"derivative":{"exercise_price":2.93,"expiration_date":"2032-08-28","underlying":"Class A Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001937915-25-000010","document":"form4-12032025_101208.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000010/form4-12032025_101208.xml","form_type":"4"}},{"id":981682,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-03T22:02:12.000Z","date":"2025-12-01","kind":"sale","planned":false,"acquired":false,"shares":150000,"price":7.8217,"value":1173255.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.80 to $7.855. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001937915-25-000010","document":"form4-12032025_101208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000010/form4-12032025_101208.xml","form_type":"4"}},{"id":981681,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-12-03T22:02:12.000Z","date":"2025-12-01","kind":"exercise","planned":false,"acquired":true,"shares":150000,"price":2.93,"value":439500.0,"ownership":{"direct":true},"balance_after":168000,"source":{"system":"sec-edgar","filing":"0001937915-25-000010","document":"form4-12032025_101208.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000010/form4-12032025_101208.xml","form_type":"4"}},{"id":987238,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:55:20.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vested as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":470000,"derivative":{"exercise_price":3.61,"expiration_date":"2032-07-14","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001937915-25-000008","document":"form4-11262025_101117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000008/form4-11262025_101117.xml","form_type":"4"}},{"id":987237,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-26T22:55:20.000Z","date":"2025-11-25","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vested as to 25% on the one year anniversary of 7/15/2022, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":480000,"derivative":{"exercise_price":3.61,"expiration_date":"2032-07-14","underlying":"Class A Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001937915-25-000008","document":"form4-11262025_101117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000008/form4-11262025_101117.xml","form_type":"4"}},{"id":987236,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-26T22:55:20.000Z","date":"2025-11-26","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":8,"value":80000.0,"ownership":{"direct":true},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001937915-25-000008","document":"form4-11262025_101117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000008/form4-11262025_101117.xml","form_type":"4"}},{"id":987235,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-26T22:55:20.000Z","date":"2025-11-26","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":3.61,"value":36100.0,"ownership":{"direct":true},"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001937915-25-000008","document":"form4-11262025_101117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000008/form4-11262025_101117.xml","form_type":"4"}},{"id":987234,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-26T22:55:20.000Z","date":"2025-11-25","kind":"sale","planned":false,"acquired":false,"shares":10000,"price":7.5,"value":75000.0,"ownership":{"direct":true},"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001937915-25-000008","document":"form4-11262025_101117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000008/form4-11262025_101117.xml","form_type":"4"}},{"id":987233,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-26T22:55:20.000Z","date":"2025-11-25","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":3.61,"value":36100.0,"ownership":{"direct":true},"balance_after":28000,"source":{"system":"sec-edgar","filing":"0001937915-25-000008","document":"form4-11262025_101117.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000008/form4-11262025_101117.xml","form_type":"4"}},{"id":990220,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":300000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vested as to 25% on the one year anniversary of 2/28/2023, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-02-27","underlying":"Class A Common Stock","underlying_shares":300000},"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990219,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":69051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options vested as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years."}],"balance_after":229884,"derivative":{"exercise_price":1.74,"expiration_date":"2030-01-21","underlying":"Class A Common Stock","underlying_shares":69051},"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990218,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":300000,"price":7.227,"value":2168100.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990217,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":300000,"price":1.94,"value":582000.0,"ownership":{"direct":true},"balance_after":300000,"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990216,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":69051,"price":7.227,"value":499031.577,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.15 to $7.43. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990215,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:09:42.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":69051,"price":1.74,"value":120148.74,"ownership":{"direct":true},"balance_after":69051,"source":{"system":"sec-edgar","filing":"0001521111-25-000006","document":"form4-11242025_091137.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000006/form4-11242025_091137.xml","form_type":"4"}},{"id":990214,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-24T21:08:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Option vested as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":450000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001937915-25-000006","document":"form4-11242025_091135.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000006/form4-11242025_091135.xml","form_type":"4"}},{"id":990213,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:08:39.000Z","date":"2025-11-20","kind":"sale","planned":false,"acquired":false,"shares":20000,"price":7.0037,"value":140074.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.00 to $7.005. The Reporting Person will provide, upon request, to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001937915-25-000006","document":"form4-11242025_091135.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000006/form4-11242025_091135.xml","form_type":"4"}},{"id":990212,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-24T21:08:39.000Z","date":"2025-11-20","kind":"exercise","planned":false,"acquired":true,"shares":20000,"price":1.87,"value":37400.0,"ownership":{"direct":true},"balance_after":38000,"source":{"system":"sec-edgar","filing":"0001937915-25-000006","document":"form4-11242025_091135.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000006/form4-11242025_091135.xml","form_type":"4"}},{"id":991467,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":63378,"kind":"person","name":"Hanley David C.","position":1,"cik":"0001865826","reported_name":"Hanley David C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPERATIONS"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-21T16:05:06.000Z","date":"2025-11-19","kind":"exercise","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":300000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001865826-25-000004","document":"form4-11212025_091102.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1865826/000186582625000004/form4-11212025_091102.xml","form_type":"4"}},{"id":991466,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":63378,"kind":"person","name":"Hanley David C.","position":1,"cik":"0001865826","reported_name":"Hanley David C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPERATIONS"}}],"security":"Class A Common Stock","published_at":"2025-11-21T16:05:06.000Z","date":"2025-11-19","kind":"sale","planned":false,"acquired":false,"shares":200000,"price":7.1384,"value":1427680.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.045 to $7.260. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001865826-25-000004","document":"form4-11212025_091102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1865826/000186582625000004/form4-11212025_091102.xml","form_type":"4"}},{"id":991465,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":63378,"kind":"person","name":"Hanley David C.","position":1,"cik":"0001865826","reported_name":"Hanley David C.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF TECHNICAL OPERATIONS"}}],"security":"Class A Common Stock","published_at":"2025-11-21T16:05:06.000Z","date":"2025-11-19","kind":"exercise","planned":false,"acquired":true,"shares":200000,"price":1.87,"value":374000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,000 shares acquired on each of May 19, 2025 and November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":224000,"source":{"system":"sec-edgar","filing":"0001865826-25-000004","document":"form4-11212025_091102.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1865826/000186582625000004/form4-11212025_091102.xml","form_type":"4"}},{"id":993928,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-19T21:47:31.000Z","date":"2025-11-19","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":470000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001937915-25-000004","document":"form4-11192025_091127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000004/form4-11192025_091127.xml","form_type":"4"}},{"id":993927,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-11-19T21:47:31.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":485000,"derivative":{"exercise_price":1.87,"expiration_date":"2034-02-27","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001937915-25-000004","document":"form4-11192025_091127.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000004/form4-11192025_091127.xml","form_type":"4"}},{"id":993926,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-19T21:47:31.000Z","date":"2025-11-19","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":5.1035,"value":76552.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.21. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 3,000 shares acquired on November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":18000,"source":{"system":"sec-edgar","filing":"0001937915-25-000004","document":"form4-11192025_091127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000004/form4-11192025_091127.xml","form_type":"4"}},{"id":993925,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-19T21:47:31.000Z","date":"2025-11-19","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":1.87,"value":28050.0,"ownership":{"direct":true},"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001937915-25-000004","document":"form4-11192025_091127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000004/form4-11192025_091127.xml","form_type":"4"}},{"id":993924,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-19T21:47:31.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":15000,"price":4.765,"value":71475.0,"ownership":{"direct":true},"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001937915-25-000004","document":"form4-11192025_091127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000004/form4-11192025_091127.xml","form_type":"4"}},{"id":993923,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-11-19T21:47:31.000Z","date":"2025-11-17","kind":"exercise","planned":false,"acquired":true,"shares":15000,"price":1.87,"value":28050.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001937915-25-000004","document":"form4-11192025_091127.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000193791525000004/form4-11192025_091127.xml","form_type":"4"}},{"id":1012083,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-10-29T20:24:30.000Z","date":"2025-10-27","kind":"exercise","planned":true,"acquired":false,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options vest as to 25% on July 1, 2020 and in equal monthly installments thereafter over the following three years."}],"balance_after":298935,"derivative":{"exercise_price":1.74,"expiration_date":"2030-01-21","underlying":"Class A Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001521111-25-000003","document":"form4-10292025_081026.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000003/form4-10292025_081026.xml","form_type":"4"}},{"id":1012082,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-29T20:24:30.000Z","date":"2025-10-27","kind":"sale","planned":true,"acquired":false,"shares":100000,"price":5.0246,"value":502460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated June 24, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $5.00 to $5.08. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001521111-25-000003","document":"form4-10292025_081026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000003/form4-10292025_081026.xml","form_type":"4"}},{"id":1012081,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":20866,"kind":"person","name":"Hattersley Gary","position":1,"cik":"0001521111","reported_name":"Hattersley Gary","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF SCIENTIFIC OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-10-29T20:24:30.000Z","date":"2025-10-27","kind":"exercise","planned":true,"acquired":true,"shares":100000,"price":1.74,"value":174000.0,"ownership":{"direct":true},"balance_after":100000,"source":{"system":"sec-edgar","filing":"0001521111-25-000003","document":"form4-10292025_081026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000152111125000003/form4-10292025_081026.xml","form_type":"4"}},{"id":1067964,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":39335,"kind":"person","name":"Mashal Robert","position":1,"cik":"0002007102","reported_name":"Mashal Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2025-08-13T20:30:14.000Z","date":"2025-08-11","kind":"gift","planned":false,"acquired":true,"shares":350001,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option are fully vested."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported transaction involves the reporting person's transfer of option to his irrevocable trust."}],"balance_after":350001,"derivative":{"exercise_price":1.55,"expiration_date":"2034-01-07","underlying":"Class A Common Stock","underlying_shares":350001},"source":{"system":"sec-edgar","filing":"0001415889-25-021652","document":"form4-08132025_080809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2007102/000141588925021652/form4-08132025_080809.xml","form_type":"4"}},{"id":1067963,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":39335,"kind":"person","name":"Mashal Robert","position":1,"cik":"0002007102","reported_name":"Mashal Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-13T20:30:14.000Z","date":"2025-08-11","kind":"gift","planned":false,"acquired":false,"shares":350001,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option are fully vested."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"The reported transaction involves the reporting person's transfer of option to his irrevocable trust."}],"balance_after":391178,"derivative":{"exercise_price":1.55,"expiration_date":"2034-01-07","underlying":"Class A Common Stock","underlying_shares":350001},"source":{"system":"sec-edgar","filing":"0001415889-25-021652","document":"form4-08132025_080809.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007102/000141588925021652/form4-08132025_080809.xml","form_type":"4"}},{"id":1106406,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35680,"kind":"person","name":"Markel Stacy","position":1,"cik":"0001734780","reported_name":"Markel Stacy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF PEOPLE OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:05:21.000Z","date":"2025-06-18","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":1.71,"value":17100.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":29591,"source":{"system":"sec-edgar","filing":"0001415889-25-017660","document":"form4-06182025_040613.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925017660/form4-06182025_040613.xml","form_type":"4"}},{"id":1106643,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":29802,"kind":"person","name":"Sauvage Philippe","position":1,"cik":"0002039891","reported_name":"Sauvage Philippe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:05:19.000Z","date":"2025-06-17","kind":"purchase","planned":false,"acquired":true,"shares":4000,"price":1.79,"value":7160.0,"ownership":{"direct":true},"balance_after":9902,"source":{"system":"sec-edgar","filing":"0001415889-25-017659","document":"form4-06182025_040610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2039891/000141588925017659/form4-06182025_040610.xml","form_type":"4"}},{"id":1106642,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":29802,"kind":"person","name":"Sauvage Philippe","position":1,"cik":"0002039891","reported_name":"Sauvage Philippe","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:05:19.000Z","date":"2025-06-16","kind":"purchase","planned":false,"acquired":true,"shares":3300,"price":1.835,"value":6055.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 2,602 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":5902,"source":{"system":"sec-edgar","filing":"0001415889-25-017659","document":"form4-06182025_040610.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2039891/000141588925017659/form4-06182025_040610.xml","form_type":"4"}},{"id":1106405,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:05:10.000Z","date":"2025-06-16","kind":"purchase","planned":false,"acquired":true,"shares":24000,"price":1.8,"value":43200.0,"ownership":{"direct":true},"balance_after":50000,"source":{"system":"sec-edgar","filing":"0001415889-25-017657","document":"form4-06182025_040604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925017657/form4-06182025_040604.xml","form_type":"4"}},{"id":1106404,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:05:10.000Z","date":"2025-06-16","kind":"purchase","planned":false,"acquired":true,"shares":26000,"price":1.79,"value":46540.0,"ownership":{"direct":true},"balance_after":26000,"source":{"system":"sec-edgar","filing":"0001415889-25-017657","document":"form4-06182025_040604.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925017657/form4-06182025_040604.xml","form_type":"4"}},{"id":1106403,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2025-06-18T20:05:05.000Z","date":"2025-06-16","kind":"purchase","planned":false,"acquired":true,"shares":500000,"price":1.787,"value":893500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":") The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.64 to $1.88, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":59281054,"source":{"system":"sec-edgar","filing":"0001415889-25-017656","document":"form4-06182025_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925017656/form4-06182025_040601.xml","form_type":"4"}},{"id":1106610,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":63418,"kind":"person","name":"Sjogren Colleen","position":1,"cik":"0002017751","reported_name":"Sjogren Colleen","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Class A Common Stock","published_at":"2025-06-18T16:05:15.000Z","date":"2025-06-16","kind":"purchase","planned":false,"acquired":true,"shares":50000,"price":1.807,"value":90350.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.795 to $1.82, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 3,000 shares acquired on May 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan."}],"balance_after":81000,"source":{"system":"sec-edgar","filing":"0001415889-25-017658","document":"form4-06182025_040607.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2017751/000141588925017658/form4-06182025_040607.xml","form_type":"4"}},{"id":1135477,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":38755,"kind":"person","name":"FALBERG KATHRYN E","position":1,"cik":"0001206977","reported_name":"FALBERG KATHRYN E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T20:05:19.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":292983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":292983,"derivative":{"exercise_price":2.03,"expiration_date":"2035-05-20","underlying":"Class A Common Stock","underlying_shares":292983},"source":{"system":"sec-edgar","filing":"0001415889-25-014418","document":"form4-05232025_040506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925014418/form4-05232025_040506.xml","form_type":"4"}},{"id":1135476,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40917,"kind":"person","name":"VERNON W ANTHONY","position":1,"cik":"0001369091","reported_name":"VERNON W ANTHONY","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T20:05:16.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":292983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":292983,"derivative":{"exercise_price":2.03,"expiration_date":"2035-05-20","underlying":"Class A Common Stock","underlying_shares":292983},"source":{"system":"sec-edgar","filing":"0001415889-25-014421","document":"form4-05232025_040510.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925014421/form4-05232025_040510.xml","form_type":"4"}},{"id":1135475,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":44250,"kind":"person","name":"BLICKENSTAFF KIM D","position":1,"cik":"0001238913","reported_name":"BLICKENSTAFF KIM D","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T20:05:16.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":292983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":292983,"derivative":{"exercise_price":2.03,"expiration_date":"2035-05-20","underlying":"Class A Common Stock","underlying_shares":292983},"source":{"system":"sec-edgar","filing":"0001415889-25-014417","document":"form4-05232025_040503.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925014417/form4-05232025_040503.xml","form_type":"4"}},{"id":1135639,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":39335,"kind":"person","name":"Mashal Robert","position":1,"cik":"0002007102","reported_name":"Mashal Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T20:05:13.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":292983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":292983,"derivative":{"exercise_price":2.03,"expiration_date":"2035-05-20","underlying":"Class A Common Stock","underlying_shares":292983},"source":{"system":"sec-edgar","filing":"0001415889-25-014420","document":"form4-05232025_040508.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007102/000141588925014420/form4-05232025_040508.xml","form_type":"4"}},{"id":1135474,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":36784,"kind":"person","name":"Bazemore Robert B","position":1,"cik":"0001620152","reported_name":"Bazemore Robert B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-23T20:05:11.000Z","date":"2025-05-21","kind":"grant","planned":false,"acquired":true,"shares":292983,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"100% of the shares subject to the option shall vest on the earlier of: (i) the one-year anniversary of the grant date (May 21, 2025); or (ii) the next shareholder annual meeting, subject to the Reporting Person's continuous service through such applicable vesting date."}],"balance_after":292983,"derivative":{"exercise_price":2.03,"expiration_date":"2035-05-20","underlying":"Class A Common Stock","underlying_shares":292983},"source":{"system":"sec-edgar","filing":"0001415889-25-014416","document":"form4-05232025_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925014416/form4-05232025_040501.xml","form_type":"4"}},{"id":1157445,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-05-06T20:05:06.000Z","date":"2025-05-02","kind":"exercise","planned":true,"acquired":false,"shares":20000,"price":1.94,"value":38800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests as to 25% on 2/28/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date"}],"balance_after":480000,"derivative":{"exercise_price":1.94,"expiration_date":"2033-02-27","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001415889-25-012096","document":"form4-05062025_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925012096/form4-05062025_040501.xml","form_type":"4"}},{"id":1157444,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-05-06T20:05:06.000Z","date":"2025-05-02","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":2.5012,"value":50024.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares sold pursuant to a 10b5-1 plan dated October 10, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Price reported is a weighted-average sales price. The shares were sold at prices ranging from $2.50 to $2.505. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":12000,"source":{"system":"sec-edgar","filing":"0001415889-25-012096","document":"form4-05062025_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925012096/form4-05062025_040501.xml","form_type":"4"}},{"id":1157443,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":51799,"kind":"person","name":"Liu Dongfang","position":1,"cik":"0001937915","reported_name":"Liu Dongfang","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Class A Common Stock","published_at":"2025-05-06T20:05:06.000Z","date":"2025-05-02","kind":"exercise","planned":true,"acquired":true,"shares":20000,"price":1.94,"value":38800.0,"ownership":{"direct":true},"balance_after":32000,"source":{"system":"sec-edgar","filing":"0001415889-25-012096","document":"form4-05062025_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925012096/form4-05062025_040501.xml","form_type":"4"}},{"id":1175695,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2025-04-09T01:30:51.000Z","date":"2025-04-07","kind":"purchase","planned":false,"acquired":true,"shares":300000,"price":1.625,"value":487500.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":") The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.54 to $1.78, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":58781054,"source":{"system":"sec-edgar","filing":"0001415889-25-010446","document":"form4-04092025_010447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925010446/form4-04092025_010447.xml","form_type":"4"}},{"id":1175694,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":40919,"kind":"person","name":"Hung David","position":1,"cik":"0001310880","reported_name":"Hung David","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"PRESIDENT AND CEO"}}],"security":"Class A Common Stock","published_at":"2025-04-09T01:30:51.000Z","date":"2025-04-04","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":1.6636,"value":332720.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $1.6499 to $1.6699, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price."}],"balance_after":58481054,"source":{"system":"sec-edgar","filing":"0001415889-25-010446","document":"form4-04092025_010447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925010446/form4-04092025_010447.xml","form_type":"4"}},{"id":1180213,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":39335,"kind":"person","name":"Mashal Robert","position":1,"cik":"0002007102","reported_name":"Mashal Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-04-03T20:05:07.000Z","date":"2025-04-01","kind":"purchase","planned":false,"acquired":true,"shares":98900,"price":1.6699,"value":165153.11,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001415889-25-009908","document":"form4-04032025_040403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2007102/000141588925009908/form4-04032025_040403.xml","form_type":"4"}},{"id":1180212,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":39335,"kind":"person","name":"Mashal Robert","position":1,"cik":"0002007102","reported_name":"Mashal Robert","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Common Stock","published_at":"2025-04-03T20:05:07.000Z","date":"2025-04-01","kind":"purchase","planned":false,"acquired":true,"shares":1100,"price":1.6655,"value":1832.05,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Shares are owned directly by the Robert D. Mashal 2020 Revocable Trust, of which Reporting Person is the sole trustee."}],"balance_after":101100,"source":{"system":"sec-edgar","filing":"0001415889-25-009908","document":"form4-04032025_040403.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2007102/000141588925009908/form4-04032025_040403.xml","form_type":"4"}},{"id":1229185,"issuer":{"id":4384,"kind":"organization","name":"Nuvation Bio Inc."},"owners":[{"id":35679,"kind":"person","name":"Wentworth Kerry","position":1,"cik":"0001369453","reported_name":"Wentworth Kerry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF REGULATORY OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-04T23:37:21.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":500000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests as to 25% on the one year anniversary of 2/28/2025, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date."}],"balance_after":500000,"derivative":{"exercise_price":1.97,"expiration_date":"2035-02-27","underlying":"Class A Common Stock","underlying_shares":500000},"source":{"system":"sec-edgar","filing":"0001415889-25-006705","document":"form4-03042025_110318.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1811063/000141588925006705/form4-03042025_110318.xml","form_type":"4"}}],"next_cursor":"2025-03-04T23:37:21.000000Z,1229185"}